Table 1.
Comparison of baseline data
|
|
UTI group (n = 91)
|
Placebo group (n = 90)
|
P value
|
| Age (year, mean ± SD) | 52.7 ± 3.8 | 53.5 ± 4.1 | 0.175 |
| Gender, n (%) | 0.705 | ||
| Male | 67 (73.63) | 64 (71.11) | |
| Female | 24 (26.37) | 26 (28.88) | |
| BMI (kg/cm2, mean ± SD) | 22.6 ± 2.1 | 23.1 ± 2.5 | 0.147 |
| Cause of disease, n (%) | 0.582 | ||
| Biliary | 61 (67.03) | 57 (63.33) | |
| Hyperlipidemic | 18 (19.78) | 19 (21.11) | |
| Alcoholic | 12 (13.09) | 14 (15.56) | |
| Smoking history, n (%) | 0.483 | ||
| Yes | 53 (58.24) | 57 (63.33) | |
| No | 38 (41.76) | 33 (36.67) | |
| Drinking history, n (%) | 0.371 | ||
| Yes | 58 (58.24) | 63 (70.00) | |
| No | 33 (41.76) | 27 (30.00) | |
| Living environment, n (%) | 0.604 | ||
| Town | 59 (64.84) | 55 (61.11) | |
| Countryside | 32 (35.16) | 35 (38.89) | |
| Past medical history, n (%) | |||
| Hypertension | 31 (34.07) | 29 (32.22) | 0.792 |
| Hyperlipidemia | 35 (38.46) | 37 (41.11) | 0.716 |
| Diabetes | 28 (30.77) | 29 (32.22) | 0.833 |
| Cholelithiasis | 17 (18.68) | 16 (17.78) | 0.875 |
| Previous pancreatitis, n (%) | 9 (9.89) | 10 (11.11) | 0.789 |
| APACHE-II score on admission (mean ± SEM) | 12.6 ± 0.8 | 12.2 ± 0.8 | 0.724 |
| Ranson score on admission (mean ± SEM) | 3.3 ± 0.3 | 3.2 ± 0.4 | 0.842 |
| Necrotizing pancreatitis | 23 (25.27) | 20 (22.22) | 0.727 |
| Time from the onset to diagnosis (hours) | 15.2 ± 6.5 | 14.6 ± 7.1 | 0.950 |
| Endoscopic bile duct drainage | 37 (40.66) | 42 (46.67) | 0.455 |
UTI: Ulinastatin: BMI: Body mass index; APACHE: Acute Physiology and Chronic Health Evaluation.